Johannes Gutenberg-Universität Mainz
- 6131/39-0
Eichentopf, Luzie; Hiemke, Christoph; Conca, Andreas et al.
Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancyFRONTIERS IN PSYCHIATRY. Bd. 13. 2022
Stickdorn, Judith; Stein, Lara; Arnold-Schild, Danielle et al.
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against TumorsACS NANO. Bd. 16. H. 3. 2022 S. 4426-4443
Brummer, Tobias; Zipp, Frauke; Bittner, Stefan
T cell-neuron interaction in inflammatory and progressive multiple sclerosis biologyCURRENT OPINION IN NEUROBIOLOGY. Bd. 75. 2022
Rampoldi, Francesca; Donato, Elisa; Ullrich, Leon et al.
T cells license immature B cells to produce a broad range of polyreactive antibodiesCELL REPORTS. Bd. 39. H. 8. 2022
Benakis, Corinne; Simats, Alba; Tritschler, Sophie et al.
T cells modulate the microglial response to brain ischemiaELIFE. Bd. 11. 2022
Bridgewood, Charlie; Wittmann, Miriam; Macleod, Tom et al.
T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17-Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune DiseasesJOURNAL OF INVESTIGATIVE DERMATOLOGY. Bd. 142. H. 10. 2022 S. 2660-2667
Schwarzenbach, Christian; Tatsch, Larissa; Vilar, Juliana Brandstetter et al.
Targeting c-IAP1, c-IAP2, and Bcl-2 eliminates senescent glioblastoma cells following temozolomide treatmentONCOLOGY RESEARCH AND TREATMENT. Bd. 45. H. SUPPL 3. 2022 S. 49-49
Nguyen, Vu Thu Thuy; Endres, Kristina
Targeting gut microbiota to alleviate neuroinflammation in Alzheimer's diseaseADVANCED DRUG DELIVERY REVIEWS. Bd. 188. 2022
Leberzammer, Julian; Agten, Stijn M.; Blanchet, Xavier et al.
Targeting platelet-derived CXCL12 impedes arterial thrombosisBLOOD. Bd. 139. H. 17. 2022 S. 2691-2705
Winkler, Rene; Magdefrau, Ann-Sophie; Piskor, Eva-Maria et al.
Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibitionONCOGENE. Bd. 41. H. 40. 2022 S. 4560-4572